Hydroxyzine Pamoate
Specifications
10246-75-0CAS Number
233-582-1EC Number
4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanolIUPAC Name
C44H43ClN2O8Chemical Formula
763.3 g/molMolecular Weight
Hydroxyzine pamoate; 10246-75-0; Hydroxyzine embonate; Atarax P; Hydroxyzyne pamoate; Hy-Pam; NSC-757063; M20215MUFR; DTXSID00907580; 2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1); Pamoate, Hydroxyzine; hy-pam ""25; RefChem:789579; HY-PAM "25; DTXCID201336670; 2-(2-(4-((RS)-(4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol mono(4,4'-methylenebis(3-hydroxy-2-naphthoate)); 233-582-1; Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, compound with 4,4'-Methylenebis(3-hydroxy-2-naphthalenecarboxylic Acid)(1:1); CHEBI:31680; Hydroxyzine (pamoate); Hydroxyzine pamoate salt; Bobsule; MLS000028605; MFCD00058051; Masmoran; Paxisitil; SMR000058728; 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethan-1-ol 4,4'-methylenebis(3-hydroxy-2-naphthoate); SR-01000003149; EINECS 233-582-1; UNII-M20215MUFR; C44H43ClN2O8; Hydroxyzine pamoate [USP:JAN]; Atarax-P (TN); Spectrum_000911; Vistaril pamoate (TN); Spectrum2_001000; Spectrum3_000463; Spectrum4_000013; Spectrum5_000838; HYYDROXYZINE PAMOATE; SCHEMBL41333; SCHEMBL41334; BSPBio_002166; KBioGR_000385; KBioSS_001391; DivK1c_000503; SPECTRUM1500345; SPBio_001099; orb1227132; orb1310988; CHEMBL1200467; HYDROXYZINE PAMOATE [MI]; SCHEMBL29359711; HMS501J05; HY-B0895R; KBio1_000503; KBio2_001391; KBio2_003959; KBio2_006527; KBio3_001386; HYDROXYZINE PAMOATE [JAN]; ASDOKGIIKXGMNB-UHFFFAOYSA-N; Hydroxyzine (pamoate) (Standard); Hydroxyzine pamoate (JP18/USP); NINDS_000503; HMS1920F11; HMS2091L19; HMS2235O19; HMS3886G14; HMS5085C07; Pharmakon1600-01500345; HYDROXYZINE PAMOATE [VANDF]; HY-B0895; CCG-40218; HYDROXYZINE EMBONATE [MART.]; HYDROXYZINE PAMOATE [USP-RS]; MSK179447; NSC757063; s5649; HYDROXYZINE EMBONATE [WHO-DD]; AKOS015914218; NSC 757063; IDI1_000503; HYDROXYZINE PAMOATE [ORANGE BOOK]; NCGC00021152-02; NCGC00021152-03; NCGC00094698-01; NCGC00094698-02; (+-)-2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1); DA-54190; FH171674; MS-31366; HYDROXYZINE PAMOATE [USP MONOGRAPH]; SBI-0051413.P003; NS00087142; D01096; F15112; SR-01000003149-2; SR-01000003149-4; Q27114645; Hydroxyzine pamoate, United States Pharmacopeia (USP) Reference Standard; (+/-)-2-(2-(4-(P-CHLORO-.ALPHA.-PHENYLBENZYL)-1-PIPERAZINYL)ETHOXY)ETHANOL 4,4'-METHYLENEBIS(3-HYDROXY-2-NAPHTHOATE) (1:1); 4,4'-Methylenebis(3-hydroxynaphthalene-2-carboxylic acid)--2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)ethan-1-ol (1/1); 4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid;2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanolSynonyms
